Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal

Faraz S Ahmad1, Xuan Cai2, Katherine Kunkel3

  • 1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Insights

Blacks with chronic kidney disease (CKD) have higher rates of left ventricular hypertrophy (LVH), a marker of heart disease. This study found Black race independently associated with concentric LVH in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Genetics

Background:

  • Chronic kidney disease (CKD) increases cardiovascular disease (CVD) risk, particularly in Black populations.
  • Left ventricular hypertrophy (LVH) is a key subclinical CVD marker, but its racial variations in CKD patients are understudied.

Purpose of the Study:

  • To compare the prevalence of different left ventricular (LV) remodeling types across racial/ethnic groups in individuals with CKD.
  • To determine if race/ethnicity is independently associated with specific LV remodeling patterns, adjusting for confounders.

Main Methods:

  • Cross-sectional analysis of the Chronic Renal Insufficiency Cohort Study.
  • Compared LV geometry types (concentric hypertrophy, eccentric hypertrophy, concentric remodeling) between non-Hispanic Black and non-Hispanic White participants.
  • Utilized multinomial logistic regression to assess independent associations between race/ethnicity and LV remodeling.

Main Results:

  • Identified 1,164 non-Hispanic Black and 1,155 non-Hispanic White participants with adequate echocardiogram data.
  • Non-Hispanic Blacks exhibited higher mean LV mass index and a greater prevalence of concentric LVH compared to non-Hispanic Whites.
  • Black race/ethnicity was independently linked to increased odds of concentric LVH, even after accounting for factors like blood pressure and antihypertensive medication use.

Conclusions:

  • Significant racial differences in LV mass and hypertrophic morphology exist among CKD patients.
  • Findings highlight potential contributors to racial disparities in CVD outcomes within the CKD population.
  • Further research is warranted to investigate the impact of LVH prevalence on CVD disparities in CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
885
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
821
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
554
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
501
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.4K